within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10A_InsulinsAndAnalogues.A10AB30_InsulinDegludecAndInsulinAspartCombination;

model InsulinDegludecAndInsulinAspartCombination
  extends Pharmacolibrary.Drugs.ATC.A.A10AB30;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A10AB30</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Insulin degludec/insulin aspart (marketed as Ryzodeg) is a fixed-ratio combination of a long-acting basal insulin (degludec) and a rapid-acting prandial insulin (aspart) used in the management of diabetes mellitus, especially type 2 diabetes. It is administered by subcutaneous injection. The combination is approved in several countries for improving glycemic control.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic estimates for healthy subjects following a single subcutaneous injection, based partly on published information for individual components; no specific population PK model for the fixed combination exists in literature.</p><h4>References</h4><ol><li><p>Biester, T, et al., &amp; Haahr, H (2016). Pharmacokinetic and prandial pharmacodynamic properties of insulin degludec/insulin aspart in children, adolescents, and adults with type 1 diabetes. <i>Pediatric diabetes</i> 17(8) 642–649. DOI:<a href=\"https://doi.org/10.1111/pedi.12358\">10.1111/pedi.12358</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26782928/\">https://pubmed.ncbi.nlm.nih.gov/26782928</a></p></li><li><p>Liu, H, et al., &amp; Yu, Y (2025). Evaluation of Pharmacokinetics and Safety of the Biosimilar (B01711) and Insulin Degludec/Insulin Aspart (IDegAsp, Ryzodeg) in Healthy Chinese Adults in a Randomized, Open-Label, Single-Dose, Crossover, Phase I Study. <i>Drug design, development and therapy</i> 19 2863–2871. DOI:<a href=\"https://doi.org/10.2147/DDDT.S500347\">10.2147/DDDT.S500347</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40236299/\">https://pubmed.ncbi.nlm.nih.gov/40236299</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end InsulinDegludecAndInsulinAspartCombination;
